¼±Åà - È»ìǥŰ/¿£ÅÍŰ
´Ý±â - ESC
KMLE °Ë»ö
°Ë»ö ¼³Á¤
¿Â¶óÀÎ ÀÇÇмÀû
ÀÇÇпë¾î »çÀü
ÀÇÇоà¾î
ÀÇÇлçÀü
ÇÑ¿µ/¿µÇÑ»çÀü
¿µ¿µ»çÀü
»çÀÌÆ® ¼Ò°³
Àç°Ë»ö
"alpha angle"¿¡ ´ëÇÑ ´ëÇÑÀÇÇù ÀÇÇпë¾î ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
4
¿µ¹®
ÇѱÛ
mandibular plane angle
¾Æ·¡ÅλÀÆò¸é°¢, ÇÏ¾ÇÆò¸é°¢
mastoid angle
²ÀÁö°¢
maxillary angle
À§Åΰ¢, »ó¾Ç°¢
mesiobuccoocclusal point angle
¾ÈÂʺ¼Âʱ³ÇÕ¸éÁ¡°¢
mesiolingual angle
¾ÈÂÊÇôÂʰ¢
mesiolingual line angle
¾ÈÂÊÇôÂʼ±°¢
mesiolinguoocclusal point angle
¾ÈÂÊÇôÂʱ³ÇÕ¸éÁ¡°¢
mesio-occlusal line angle
¾ÈÂʱ³Çո鼱°¢, ¾ÈÂʸ¹°¸²¸é¼±°¢
narrow angle
Á¼Àº¾Õ¹æ°¢, ÇùÀü¹æ°¢
narrow-angle glaucoma
Á¼Àº¾Õ¹æ°¢³ì³»Àå, ÇùÀü¹æ°¢³ì³»Àå
nasofrontal angle
ÄÚÀ̸¶°¢
nasolabial angle
ÄÚÀÔ¼ú°¢
ocular angle
´«±¸¼®, ¾È°¢
open-angle glaucoma
°³¹æ°¢³ì³»Àå
oral angle
ÀÔ²¿¸®
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
4
¿µ¹®
ÇѱÛ
narrow angle
Á¼Àº¾Õ¹æ°¢, ÇùÀü¹æ°¢
nasofrontal angle
ÄÚÀ̸¶°¢
nasolabial angle
ÄÚÀÔ¼ú°¢
neovascularization angle
¾Õ¹æ°¢Ç÷°ü½Å»ý
ocular angle
´«±¸¼®
oral angle
ÀÔ²¿¸®
phrenicocostal angle
°¡·Î¸·°¥ºñ°¢
sacrovertebral angle
(¢¡lumbosacral angle) Ç㸮¾ûÄ¡°¢
septal angle
ÄÚÁ߰ݰ¢, ºñÁ߰ݰ¢
sphenoidal angle
³ªºñ°¢
sternal angle
º¹Àå»À°¢
subpubic angle
µÎµ¢¾Æ·¡°¢
tip-columellar angle
ÄÚ³¡ÄÚ±âµÕ°¢
venous angle
Á¤¸Æ°¢
visual angle
½Ã°¢°¢
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
4
¿µ¹®
ÇѱÛ
precession angle
¼¼Â÷ °¢
primary angle-closure glaucoma
¿ø¹ßÆó¼â°¢³ì³»Àå
primary open-angle glaucoma
¿ø¹ß°³¹æ°¢³ì³»Àå
pubic angle ³ª angulus pubis
Ä¡°ñ°¢ (ö»ÍéÊÇ).
renal angle
½Å°¢.
17-alpha-hydroxycorticosteroid
17-¾ËÆÄ-È÷µå·Ï½ÃÄÚ¸£Æ¼ÄÚ½ºÅ×·ÎÀ̵å
17-alpha-hydroxyprogesterone
17-¾ËÆÄ-È÷µå·Ï½ÃÇÁ·Î°Ô½ºÅ×·Ð
alpha behavior
¾ËÆÄÇàÀ§
alpha blocking
¾ËÆÄÂ÷´Ü
alpha cell
¾ËÆÄ¼¼Æ÷
alpha cell
¾ËÆÄ¼¼Æ÷(¡á¬øà)
alpha cell glucagon cell
¾ËÆÄ¼¼Æ÷ ±Û·çÄ«°ï¼¼Æ÷
alpha cell tumor
¾ËÆÄ ¼¼Æ÷Á¾(¡á¬øàðþ)
alpha chain disease
¾ËÆÄ¼âº´(¡áðÜ»).
alpha chain disease
¾ËÆÄ¼âÁúȯ
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
4
¿µ¹®
ÇѱÛ
alpha-fucosidase
¾ËÆÄ-ǪÄڽôÙÁ¦(¡ð¥)
alpha-ketoglutarate
¾ËÆÄ-ÄÉÅä±Û·çŸ·¹ÀÌÆ®
alpha-l-iduronidase
a-L-Iduronidase
alpha-lipoproteinemia
¾ËÆÄ-Áö¹æ´Ü¹éÇ÷Áõ
alpha-naphthyl acetate esterase
¾ËÆÄ-³ªÇÁÆ¿¾Æ¼¼Å×ÀÌÆ®¿¡½ºÅ×¶óÁ¦
alpha-naphthyl acetate esterase =ANAE
¾ËÆÄ¾Æ¼¼Å×ÀÌÆ®¿¡½ºÅ×¶óÁ¦
alpha-naphthyl butyrate esterase
¾ËÆÄ-³ªÇÁÆ¿ ºÎƼ·¹ÀÌÆ®¿¡½ºÅ×¶óÁ¦
alpha-naphthyl butyrate esterase =ANBE
¾ËÆÄºÎƼ·¹ÀÌÆ®¿¡½ºÅ×¶óÁ¦
alpha-naphthylamine
¾ËÆÄ-³ªÇÁÆ¿¾Æ¹Î
alpha-sympathomimetic agent
¾ËÆÄ±³°¨½Å°æÀ¯»çÀÛ¿ëÁ¦
alpha-thalassemia trait
¾ËÆÄ-Å»¶ó¼¼¹Ì¾Æ ¼ÒÀÎ
alpha/beta (¥á/¥â) ratio
¥á/¥â ºñ
chain, alpha (¥á)
¾ËÆÄ»ç½½, ¾ËÆÄ¼â
cowpea(alpha-borne) mosaic virus
Ä«¿ìÇÇ ¸ðÀÚÀÌÅ©¹ÙÀÌ·¯½º
galactosidase, alpha-galactosidase a, deficiency
#NAME?
ÀÌÀü
´ÙÀ½
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
4
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
4
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
4
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
4
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
4
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
4
¿µ¹®
ÇѱÛ
ÀÌÀü
ÅëÇÕ°Ë»ö ¿Ï·á
ÀÌÀü
´ÙÀ½